Intuitive Surgical (ISRG) Long-Term Investments (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Long-Term Investments came in at $3.4 billion in Q2 2026, down 18.94% year-on-year from $4.2 billion in Q2 2025, and down 1.52% quarter-over-quarter from $3.5 billion in Q1 2026.
Intuitive Surgical (ISRG) Long-Term Investments (2009 - 2026) Analysis & Trends
Intuitive Surgical's Long-Term Investments history runs 18 years deep, the most recent figure standing at $3.4 billion for Q2 2026.
- On a quarterly basis, Long-Term Investments fell 18.94% year-over-year to $3.4 billion in Q2 2026; TTM through Jun 2026 was $3.4 billion, a 18.94% decrease from a year earlier, with the FY2025 full-year figure at $3.1 billion, down 35.69% from the prior year.
- Long-Term Investments retreated to $3.4 billion in Q2 2026 per ISRG's latest filing, from $3.5 billion in the prior quarter.
- Across five years, Long-Term Investments topped out at $4.8 billion in Q4 2024 and bottomed at $1.0 billion in Q3 2023.
- The 5-year median for Long-Term Investments is $3.3 billion (2025), against an average of $3.2 billion.
- Across the five-year window, Long-Term Investments plunged 66.05% in 2023 and surged 290.45% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $2.6 billion in 2022, then declined by 19.19% to $2.1 billion in 2023, then surged by 127.32% to $4.8 billion in 2024, then sank by 35.69% to $3.1 billion in 2025, then increased by 10.01% to $3.4 billion in 2026.
- Per Business Quant, the three latest ISRG Long-Term Investments figures stand at $3.4 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.1 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 800.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 207.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.41 Bn |
| Mar 31, 2026 | 3.46 Bn |
| Dec 31, 2025 | 3.10 Bn |
| Sep 30, 2025 | 3.52 Bn |
| Jun 30, 2025 | 4.21 Bn |
| Mar 31, 2025 | 4.59 Bn |
| Dec 31, 2024 | 4.82 Bn |
| Sep 30, 2024 | 4.08 Bn |
| Jun 30, 2024 | 2.93 Bn |
| Mar 31, 2024 | 2.52 Bn |
| Dec 31, 2023 | 2.12 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.89 Bn |
| Dec 31, 2022 | 2.62 Bn |
| Sep 30, 2022 | 3.08 Bn |
| Jun 30, 2022 | 3.74 Bn |
| Mar 31, 2022 | 4.42 Bn |
| Dec 31, 2021 | 4.42 Bn |
| Sep 30, 2021 | 4.13 Bn |